tracking the news, one byte at a time
Freak Pulse

New Drug Trials and Approvals this week: Biogen’s Phase 2 CELIA study of its tau-targeting antisense oligonucleotide diranersen (BIIB080) showed a clinically; and Biogen has announced topline results from the 18-month Phase 2 CELIA study…

Research, Treatment, and Policy Developments this week: A 2026 Swedish cohort study in *BMJ Mental Health* finds adults with comorbid ADHD and substance use disorder (SUD); and This week’s research roundup highlights a tightening focus on…

Neurodiversity in the Workplace: Accommodations and Employment this week: Workplace expert Dr.

Understanding and Diagnosing Autism, ADHD, and AuDHD this week: An article from the Autistic Self-Advocacy Network outlines systemic and social reasons why autistic adults; and A national survey commissioned by Ohio State University finds…

Lunar Signals this week: This matters for Space Exploration because it gives a concrete current signal to track: Robotics will play a; and This matters for Space Exploration because it gives a concrete current signal to track: This…

Artemis Signals this week: This matters for Space Exploration because it gives a concrete current signal to track: NASA’s Artemis III Moon; and This matters for Space Exploration because it gives a concrete current signal to track: NASA…

Nasa Signals this week: This matters for Space Exploration because it gives a concrete current signal to track: NASA announced Wednesday; and This matters for Space Exploration because it gives a concrete current signal to track: NASA’s…

Nasa Signals this week: NASA has awarded Interlune a $6.9 million, 18-month Phase III SBIR contract to develop flight-ready hardware for; and NASA’s Psyche spacecraft will execute a gravity-assist flyby of Mars on May 15, passing within…

Frontotemporal Signals this week: A clinical review outlines the severe limitations and risks of psychotropic medication for managing neuropsychiatric; and This matters for Alzheimer’s Disease and Frontal Temporal Dementia because it…